Population Science Studies
Project Title |
Grant Number |
Principal Investigator |
Institution |
Sample Size |
Diagnosis Years |
Project Start & End Years |
Risk Factors for Ductal Carcinoma In Situ |
5R03CA103478-02 |
Brody, Julia |
Silent Spring Institute |
n=224 patients from the Cape Cod Breast Cancer and Environment Study |
1992-1998 |
2003-2006 |
Breast Carcinoma In-Situ: Mammographic Risk Factors |
5R01CA095560-03 |
Claus, Elizabeth |
Yale University |
n=875 with DCIS; n=123 with LCIS who are CT residents; n=999 controls |
1994-1998 |
2004-2010 |
Cost-Effectiveness -- Treatments -- Ductal Carcinoma In Situ |
5R01CA092444-02 |
Dick, Andrew / Griggs, Jennifer |
University of Rochester |
SEER-Medicare |
|
2002-2005 |
Microsatellite Markers of DCIS Prognosis |
5R21CA081442-02 |
Gabrielson, Edward |
Johns Hopkins Universtiy |
|
|
1999-2002 |
Risk Stratification for Subsequent Tumors in Women with DCIS |
5P50CA058207-15001209 |
Gray, Joe |
University of California, San Francisco |
Large, established, well-characterized population-based cohort of women with DCIS treated by lumpectomy alone with 8.1 years of follow-up |
|
|
Etiology of Early Breast Malignancy |
5R01CA072025-04 |
Greenberg, Robert |
Dartmouth College |
n=412 women with DCIS from NH and VT cancer registries
n=412 women with invasive breast cancer |
|
1996-2002 |
DCIS--Mammographic features and prognosis |
5R01CA081302-05 |
Habel, Laurel |
Kaiser Foundation Research Institute |
n=1200 women with DCIS from the Northern California Kaiser Permanente Medical Care Program |
1990-1997 |
1999-2005 |
Mammographic density and breast cancer after diagnosis of DCIS |
5R03CA083135-02 |
Habel, Laurel |
Kaiser Foundation Research Institute |
n=814 patients from the National Surgical Adjuvant Breast and Bowel Program Clinical Trial |
|
1999-2002 |
Clinical/Pathologic Predictors for Recurrence after DCIS |
2U19CA079689-050001 |
Habel, Laurel |
Kaiser Foundation Research Institute |
n=3700 patients (n=490 with recurrence) from the CRN, Kaiser Permanente Northern California, Kaiser Permanente Souther California, Harvard Pilgrim Health Care |
1990-2001 |
2003-2007 |
Surgical Treatment for Early State Breast Cancer |
5R01CA088370-03 |
Katz, Steven |
University of Michigan, Ann Arbor |
n=1880 patients from SEER catchment areas |
|
2001-2005 |
Predictors of Recurrence in Women with DCIS |
2P50CA058207-090011 |
Kerlikowse, Karla |
University of California, San Francisco |
n=1,744 from Northern California SEER
n=457 from UCSF for the Breast Oncology Program database
n=1,3 10 women from the NSABPB-17 and NSABPB-24 trials. |
1983-1996 |
2003-2007 |
Radiation and Genomic Instability in Finite Lifespan Human Mammary Epi |
1R21ES016889-01A1 |
Kronenberg, Amy |
University of California |
Mammary epithelial cells |
|
2009-2011 |
Treatment Decisions Comparing DCIS/Invasive BC patients |
1R03CA075140-01A1 |
Lantz, Paula |
University of Michigan, Ann Arbor |
n=200 patients with DCIS or invasive breast cancer reported to Detroit SEER Registry |
|
1997-1999 |
Breast Cancer: Role of Early Detection, Treatment and Prevention |
5U01CA088270-07 |
Lee, Sandra J. |
Dana-Farber Cancer Institute |
SEER data |
|
2000-2009 |
Risk Factors for Second Primary Breast Cancer Among DCIS Survivors |
5R01CA097271-07 |
Li, Christopher |
Fred Hutchinson Cancer Research Center |
n=515 cases diagnosed with DCIS and a subsequent second primary in situ or invasive breast cancer, n=1,030 controls with DCIS only |
|
2002-2014 |
A Video DVD Program to Assist with Informed Consent |
1R43CA103264-01A1 |
Love, Neil |
NL Communications, Inc |
n=3000 |
|
2004-2005 |
Case-Control Study of Carcinoma In Situ |
3P50CA058223-08S20011 |
Millikan, Bob |
University of North Carolina Chapel Hill |
n=400 cases of DCIS or LCIS from the Carolina Breast Cancer Study and frequency-matched controls |
1995-2000 |
Not listed |
Risk Factors and Biomarkers for In Situ Breast Cancer |
5R01CA067264-04 |
Newcomb, Polly and Titus-Ernstoff, Linda |
Fred Hutchinson Cancer Research Center and Dartmouth College |
n=1575 cases of DCIS or LCIS from WI, MA, and NH state cancer registries
n=2205 population-based controls |
|
1996-2002 |
Cost Effectiveness Analysis of Breast Cancer Screening |
5R01CA082904-03 |
Plevritis, Sylvia |
Stanford University |
|
|
1999-2003 |
Breast Cancer Trend Analysis Using Stochastic Stimulati |
3U01CA088248-04S1 |
Plevritis, Sylvia |
Stanford University |
|
|
2000-2011 |
Decision-making Regarding Radiation Therapy in Breast Cacner |
5K07CA118269-05 |
Punglia, Rinaa |
Dana Farber Cancer Institute |
SEER-Medicare data |
|
2006-2011 |
Environmental and Genetic Risk Factors for Breast Cancer: The Sister Study |
1ZIAES044005-12 |
Sandler, Dale |
National Institute of Environmental Health Sciences |
NIEHS Sister Study |
2004-2009 |
Ongoing |
Breast Carcinoma in Situ: Predicting Risk and Outcomes |
5R01CA067264-12 |
Trentham-Dietz, Amy |
University of Wisconsin, Madison |
n=2,352 cases from large, population-based cohort n=>5,000 controls |
|
1996-2014 |
Clinical Studies
Project Title |
Grant Number |
Principal Investigator |
Institution |
Sample Size |
Project Start & End Years |
Clinical Study of the Disposition and Biological Activity of d-Limonene |
|
Chow, Sherry |
University of Arizona |
Women with a recent diagnosis of DCIS, LCIS, or atypical ductal hyperplasia |
2009-2011 |
A her-2/neu Pulsed DC1 Vaccine for Patients with DCIS |
5R01CA096997-03 |
Czerniecki, Brian |
University of Pennsylvania |
Practice-based recruitment |
2003-2012 |
Addressing the Challenges in Transitioning from Mammography to Breast Tomosynthesis |
5K25CA140858-02 |
Das, Mini |
University of Massachusetts |
|
2009-2014 |
Accuracy of Breast Pathology and the Impact of Technology and Double Reading |
1R01CA140560-01 |
Elmore, Joann |
University of Washington |
Women undergoing breast biopsy |
2009-2014 |
Cytogenic Screening of Mammary Epithelial Cells |
5R21CA084712-02 |
Haddad, Bassem |
Georgetown University |
n=50 controls; n=50 women with atypical ductal hyperplasia; n=50 women with DCIS; n=50 women with stage 1 breast cancer |
2000-2003 |
Quantitative Mechanical Imaging for Improving Breast Ultrasound Diagnosis |
1R01CA140271-01 |
Hall, Timothy |
University of Wisconsin Madison |
|
2009-2014 |
High-resolution Whole-breast MRI at 3.0T |
5R01EB009055-02 |
Hargreaves, Brian |
Stanford University |
Small patient study |
2008-2012 |
Primary Hormonal Therapy for DCIS of the Breast |
5K23CA097181-04 |
Hwang, Shelley |
University of California, San Francisco |
n=40 postmenopausal patients with DCIS |
2004-2010 |
MRI for Staging DCIS and Assessing Response to Treatment |
1R01CA116182-01A1 |
Hylton, Nola |
University of California, San Francisco |
Patients with biopsy-proven DCIS |
2006-2011 |
A Trial of Exemestane in Postmenopausal Women with DCIS or at High Risk for Invasive Breast Cancer |
5M01RR023942-03 |
Isaacs, Claudine |
Georgetown University |
Women with DCIS or high risk of breast cancer |
2009-2010 |
PNI and Decision Making in Women Diagnosed with DCIS |
5R01NR008412-04 |
Janusek, Linda |
Loyola University of Chicago |
n=122 women with newly diagnosed DCIS |
2004-2008 |
Quality of Life Over Time: DCIS vs Early Breast Cancer |
5R01CA102777-04 |
Jeffe, Donna |
Washington University |
Women with normal or benign mammograms will be identified surgeons |
2003-2010 |
Synergy of Inverse Scatter & Vibro-Acoustics |
1R43CA105916-01 |
Johnson, Steven |
Techniscan, Inc |
Patients selected from a population with positive mammograms for micro calcifications |
2004-2006 |
Fast Spectroscopic MR Imaging of Breast Cancer |
5R01CA078803-07 |
Karczmar, Gregory |
University of Chicago |
n=300 women scheduled for routine MRI exams prior to biopsy |
1999-2008 |
A Tool for Analysis of Gene-specific DNA Methylation in Clinical Samples |
5R21RR024420-03 |
Levenson, Victor |
Rush University Medical Center |
|
2009-2011 |
Determination of Distinct Types of Immune Responses to HER-2/neu Associated With… |
5M01RR000065-47 |
Manjili, Masoud |
Virginia Commonwealth University |
Women with HER-2/neu positive or negative DCIS and invasive breast cancer |
2009-2010 |
Immune Dysregulation by Psychosocial Distress |
5R21CA117261-02 |
Mathews, Herbert |
Loyola University of Chicago |
Women diagnosed with DCIS |
2005-2008 |
Interactive Decision Making Program for DCIS |
5R03CA070717-02 |
Mort, Elizabeth |
Massachusetts General Hospital |
|
1995-1999 |
New Approaches to Sampling and Analyzing Contrast Media |
5R21CA104774-02 |
Newstead, Gillian |
University of Chicago |
n=150 patients per year |
2005-2008 |
Cyclin E Expression in Human Cancer |
5R01CA071735-06 |
Porter, Peggy |
Fred Hutchinson Cancer Research Center |
n=225 tissue samples from women with DCIS
n=913 tissue samples from women with invasive breast cancer |
2000-2004 |
Sulforaphane: A Dietary HDAC Inhibitor and Prevention of DCIS Progression |
1R21CA132236-01A2 |
Shannon, Jackilen |
Oregon Health and Science University |
|
2009-2011 |
Genetic Predictors of Progression of Premalignant Breast Disease |
5P50CA098131-07000809 |
Smith, Jeffrey |
Vanderbilt University |
Samples of breast tissue from a cohort of 7,923 women |
2009-2011 |
Point-of-Care Microfluidics for Early Detection of Cancer |
1U01EB012493-01 |
Toner, Mehmet |
Massachusetts General Hospital |
|
2010-2015 |
Detecting Breast Cancer Protein Signatures in Body Fluid |
5U01CA085082-05 |
Trock, Bruce |
Johns Hopkins University |
fresh tumor tissue that contains invasive, in-situ and abnormal components; body fluids from women with normal breasts, DCIS, and stage 1 cancer |
1999-2005 |
EGFR Pathway Modulation in DCIS of the Breast |
5R21CA101357-02 |
Truica, Christina |
Vanderbilt University |
Patients with DCIS |
2003-2005 |
Ex Vivo Clinical Raman Spectroscopy of Breast Cancer |
5P41RR002594-25 |
Volynskaya, Zoya |
Massachusetts Institute of Technology |
|
2010-2011 |
The HMO Cancer Research Network (CRN) - Clinical and Pathologic Predictors for Recurrence after DCIS |
3U19CA079689-08S2 |
Wagner, Edward H. |
Group Health Research Institute |
HMO-CRN data |
1999-2007 |
Psychosocial outcomes/health behaviors: women with DCIS |
3P50CA089393-05S20007 |
Winer, Eric |
Dana Farber Cancer Institute |
n=450 women from academic and community health care institutions |
Not listed |
Basic Science Studies
Project Title |
Grant Number |
Principal Investigator |
Institution |
Sample |
Project Start & End Years |
Molecular Classification and Prognostic Profiling of Ductal Carcinoma in Situ |
2P50CA058183-090010 |
Allred, Craig |
Baylor College of Medicine |
n=25 fresh-frozen DCIS samples and matched cases of normal breast and invasive breast cancer |
2003-2007 |
Role of Cancer Stem Cells in Malignant Progression of Ductal Carcinoma in Situ |
1K99CA127462-01 |
Behbod, Fariba |
University of Kansas Medical Center |
Premalignant cell lines and subtypes of human DCIS |
2007-2011 |
Role of Stat3 in Breast Cancer Tumorigenesis |
3R01CA087637-05S1 |
Bromberg, Jacqueline |
Sloan-Kettering Institute for Cancer Research |
Cell lines, transgenic animals, human tissue |
2001-2006 |
Genetic Pathways Altered by MMTV in Mouse Mammary Tumors |
1ZIABC011066-03 |
Callahan, Robert |
NCI Division of Basic Sciences |
Mouse model |
2008-2010 |
Telomere induced senescence as a suppressor of tumorigenesis |
1R01CA129037-01 |
Chang, Sandy S. |
University of Texas MD Anderson Can Ctr |
Mouse model |
2007-2012 |
Characterization of the Chromosome 17q23 Amplicon |
5R01CA087898-05 |
Couch, Fergus |
Mayo Clinic College of Medicine |
Breast tumors and cell lines |
2002-2008 |
VPF/VEGF in Breast Cancer Angiogenesis |
5R01HL054465-04 |
Dvorak, Harold |
Beth Israel Deaconess Medical Center |
Human breast lesions and carcinomas from mice |
1995-2000 |
HER4 Isoforms: Tumor Suppressor Action and Prognostic Significance |
5P50CA058223-17002509 |
Earp, Henry |
University of North Carolina Chapel Hill |
Human breast cancer cells; Mouse model |
2009-2011 |
Expression of Aryl Hydrocarbon Receptor in Breast Tumors |
5U54CA091408-020004 |
Elton, Sakina |
Meharry Medical College |
Human breast cancer cell lines |
Not listed |
Integrated Biomarkers to Characterize Breast Cancer Risk |
5U01CA111234-03 |
Esserman, Laura |
University of California San Francisco |
|
2004-2009 |
Development and Validation of a Panel of Breast Cancer for the Early Diagnosis of |
1R01CA122277-01A2 |
Fernandez-Madrid, Felix |
Wayne State University |
Human sera |
2008-2011 |
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas |
5R01CA107012-07 |
Friedl, Andreas |
University of Wisconsin |
Human breast carcinoma samples |
2004-2015 |
A Hypersensitive ERa Mutant in Breast Cancer Progression |
5R01CA072038-10 |
Fuqua, Suzanne |
Baylor College of Medicine |
Clinical breast tumor bank |
1996-2008 |
Molecular Variants of Estrogen and Progesterone Receptors in Breast Cancer |
5P01CA030195-160014 |
Fuqua, Suzanne |
Baylor College of Medicine |
|
Not listed |
Mechanisms Regulating Reversal of Malignancy |
5R01CA089041-08 |
Furth, Priscilla |
Georgetown University |
Mouse model |
2006-2010 |
Progression and Regression of Mammary Preneoplasia |
5R01CA112176-03 |
Furth, Priscilla |
Georgetown University |
Mouse model |
2004-2009 |
Somatic Genetic Changes in Early Breast Cancer |
5R21CA106676-03 |
Geradts, Joseph |
Roswell Park Cancer Institute |
n=35 low grade DCIS samples, n=35 low grade DCIS samples associated with an invasive component |
2005-2008 |
Immunologic Studies in Mouse and Human Breast Cancer |
|
Girardi, Anthony |
Coriell Institute for Medical Research |
|
|
Secreted Proteins as Breast Cancer Prevention Markers |
5R01CA101201-05 |
Gould, Michael |
University of Wisconsin, Madison |
Rat model |
2003-2008 |
Neu Activation and the Etiology of Mammary Cancer |
5R01CA058328-05 |
Gould, Michael |
University of Wisconsin, Madison |
Cell lines |
1993-1999 |
Characterizing a Breast Cancer Modifier Locus that Associated with Human Risk |
1R01CA123272-01 |
Gould, Michael |
University of Wisconsin, Madison |
Rat models and human studies |
2006-2011 |
Modulation of Carcinogenesis by Monoterpenoids |
2R37CA038128-10 |
Gould, Michael |
University of Wisconsin, Madison |
Cell lines |
1984-2000 |
Chemoprevention in a Mouse Model of DCIS |
1R03CA117465-01A2 |
Gregg, Jeffrey |
University of California, Davis |
Mouse model |
2007-2009 |
R-Cadherin in Breast Cancer Suppression |
5R01CA136854-02 |
Hazan, Rachel |
Albert Einstein College of Medicine |
Cell lines |
2009-2014 |
Autoantibodies Against Glycopeptide Epitopes as Serum Biomarkers of Cancer |
1U01CA128437-01 |
Hollingsworth, Michael A |
University of Nebraska Medical Center |
Human tissue samples |
2007-2012 |
Beta-Catenin/TCF Signaling in Breast Cancer |
1R01CA131219-01A1 |
Howe, Louise R. |
Weill Medical College of Cornell Univ. |
Precancerous breast lesions and invasive breast cancers |
2008-2013 |
CPG Island Methylator Phenotypes in Breast Cancer |
2R01CA069065-10A1 |
Huang, Tim H-M |
Ohio State Universtiy |
Human breast tumors |
2007-2012 |
Wwox as a Critical Signal Mediator in Breast Can |
5R01CA120516-02 |
Huebner, Kay |
Ohio State Universtiy |
Breast cancer cell line and tissue |
2006-2009 |
Discovery and Clinical Validation of Cancer Biomarkers Using Printed Glycan Array |
1U01CA128526-01 |
Huflejt, Margaret Elisabeth |
Cellexicon, Inc. |
Human sera |
2007-2012 |
Cancer Prevention by Selenium-Enriched Allium Vegetables |
5R01CA027706-23 |
Ip, Clement |
Roswell Park Cancer Institute |
|
1980-2005 |
Molecular biomarkers of selenium chemoprevention |
5R01CA091990-05 |
Ip, Clement |
Roswell Park Cancer Institute |
Human breast cell lines, mouse and rat models |
2002-2008 |
Pilot -- AH Receptor in Human Breast Tumors |
5U54CA091405-020004 |
Jensen, Roy |
Vanderbilt University |
Human breast carcinoma cell lines |
Not listed |
Characterizing the Evolution of Pre-malignant Tissues at High Risk for Malignancy |
5R01CA135626-02 |
Jones, Ella |
University of California San Francisco |
|
|
Biophysical Regulation of Breast Differentiation |
5R01CA114462-02 |
Keely, Patricia J |
University of Wisconsin |
Human breast carcinoma samples |
2010-2014 |
Role of EZH2 in Breast Cancer Progression |
2R01CA107469-06A1 |
Kleer, Celina G. |
University of Michigan at Ann Arbor |
Human tissue samples and mouse models |
2004-2015 |
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer |
1R01CA125577-01A1 |
Kleer, Celina G. |
University of Michigan at Ann Arbor |
Human tissue samples and mouse models |
2008-2013 |
Characterization of HIN1 Putative Tumor Supressor |
5F32CA094787-02 |
Krop, Ian |
Dana Farber Cancer Institute |
Normal and DCIS mammary epithelial cells |
2002-2003 |
DNA Repair and Breast Cancer |
5R29CA071894-05 |
Latimer, Jean |
Magee Women's Health Corporation |
Tumor and non-tumor breast epithelium |
1997-2005 |
Genomic Instability and Etiology of Extrogen Oncogenesis |
5R01CA102849-05 |
Li, Jonathan |
University of Kansas Medical Center |
|
2003-2008 |
Application of Genomic Microarrays to Breast Cancer |
5K01CA093634-05 |
Lucito, Robert |
Cold Spring Harbor Laboratory |
|
2002-2007 |
Differential Protein Expression by MALDI TOF MS |
5R21CA083808-02 |
Lubman, David |
University of Michigan, Ann Arbor |
Human breast epithelial cell line |
2001-2004 |
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease |
R01CA131990-02 |
Mattingly, Raymond |
Wayne State University |
Cell lines |
2008-2013 |
Functional Genomics of Breast Cancer |
1ZIABC011088-03 |
Meltzer, Paul S |
NCI Division of Basic Sciences |
|
2009-2010 |
MCF10DCIS.com As a Preclinical Chemopreventive Screen |
5R03CA094333-02 |
Miller, Fred |
Wayne State University |
Human breast epithelial cell line |
2002-2005 |
Proteomics of Progression in MCF10 Xenograft Model |
5R01CA090503-04 |
Miller, Fred |
Wayne State University |
Human breast cell line |
2002-2007 |
VP Peptides and Receptors in Diagnosis of Breast Cancer |
5R21CA102434-02 |
North, William |
Dartmouth College |
|
2005-2007 |
GRSA Proteins in the Diagnosis of Breast Cancer |
5R21CA092506-02 |
North, William |
Dartmouth College |
|
2001-2004 |
Molecular Genetic Markers of Pre-Malignant and Pre-Invasive Breast Disease |
3P50CA058183-08S80004 |
O'Connell, Peter |
University of Texas Health Sciences Center |
Breast cancer specimens |
Not listed |
Translational Research in Breast Cancer |
5P50CA058183-13 |
Osborne, Kent |
Baylor College of Medicine |
|
1992-2007 |
Treatment of Breast Cancer with MAG-1 Antibody |
5R44CA119483-03 |
Pang, Roy |
Woomera Therapeutics, Inc. |
Mouse model |
2006-2011 |
Manipulating b1 integrin to enhance radiation therapy for breast cancer |
1R01CA124891-01A2 |
Park, Catherine C. |
University of Calif-Lawrenc Berkeley Lab |
Cell lines |
2008-2013 |
Human Aldo Keto Reductases and Steroid Hormone Ac |
5R01CA090744-05 |
Penning, Trevor |
University of Pennsylvania |
Human breast cell lines and biopsy samples |
2001-2007 |
Molecular Characterization of Breast Basal-like Tumors |
5R01CA101227-05 |
Perou, Charles |
University of North Carolina Chapel Hill |
Human basal-like tumors; Mouse mammary tumors |
2003-2010 |
Breast stem cell analysis in random periareolar fine needle aspirates from high r |
1R03CA121417-01A1 |
Petroff, Brian |
University of Kansas Medical Center |
Samples of breast tissue from women at high risk for breast cancer |
2007-2009 |
Myoepithelial Cell Differentiation Defects in Ductal Carcinoma in situ |
5U01CA143233-02 |
Polyak, Kornelia |
Dana Farber Cancer Institute |
Human breast tissue |
2009-2014 |
Molecular Markers in DCIS |
3P50CA089393-05S20004 |
Polyak, Kornelia |
Dana Farber Cancer Institute |
Benign, in situ, invasive breast tissue |
Not listed |
HIN-1, A Novel Putative Breast Tumor Supressor Gene |
5R01CA094074-05 |
Polyak, Kornelia and Porter, Dale |
Dana Farber Cancer Institute |
Normal and cancerous breast tissue, and mouse model |
2002-2008 |
Identification of Receptor for Tumor Suppressor HIN-1 |
5F32CA094788-02 |
Porter, Dale |
Dana Farber Cancer Institute |
Mammary epithelial cells |
2002-2004 |
Epithelial-Stromal Cell Interactions in Breast Cancer |
1R01CA116235-01A1 |
Polyak, Kornelia |
Dana Farber Cancer Institute |
Human xenograft models in mice and human breast tumors |
2006-2011 |
Immune Response to Breast Ductal Carcinoma In Situ |
5K11AI001092-05 |
Pruitt, Scott |
Duke University |
Guinea pig-to-Lewis rat model |
1992-2000 |
Genetic Signatures of Preinvasive Breast Disease |
1R21CA115434-01A2 |
Rosenberg, Carol |
Boston Medical Center |
Breast cancer-containing tissue |
2007-2009 |
Molecular Basis of Breast Cell Transformation |
3R01CA067238-04S3 |
Russo, Jose |
Fox Chase Cancer Center |
Human breast epithelial cells |
1995-2000 |
Centrosome Hypertrophy in Human Breast Tumors |
5R01CA072836-04 |
Salisbury, Jeffrey |
Mayo Clinic College of Medicine |
Normal breast epithelial and breast tumor cell lines, and human breast tissue |
1998-2001 |
The Role of Cripto in the Pathogeneis of Breast and Colon Cancer |
1Z01BC009003-24 |
Salomon, David |
National Cancer Institute |
|
Ongoing |
Prevention of Breast Cancer with Sphingolipids |
5R03CA101125-02 |
Schmelz, Eva |
Wayne State University |
Cell models for early and late stages of breast cancer |
2003-2006 |
IRS-2 Function in Tumor Progression and Metastasis |
1R01CA142782-01A1 |
Shaw, Leslie |
University of Massachusetts |
Breast cancer cells |
2010-2015 |
Proteolytic Pathways in Progression of Pre-malignant Breast Disease |
5R01CA131990-03 |
Sloane, Bonnie |
Wayne State University |
Cell lines |
2008-2013 |
Molecular Markers for High Risk of Breast Cancer |
3P50CA058207-08S50003 |
Smith, Helene |
University of California, San Francisco |
Cases of pure DCIS and DCIS associated with invasive cancers, and nonmalignant epithelium samples |
Not listed |
Technology for Global and Quantitative Proteome Analysis |
1R21CA093306-01 |
Smith, Richard |
Battelle Pacific Northwest Laboratories |
Breast tissue |
2001-2003 |
Mechanisms of Mammary Gland Carcinogenesis of Heterocycl |
1Z01BC010037-10 |
Snyderwine, Elizabeth |
National Cancer Institute |
Rat model, human breast tissue |
2005 |
Molecular Alterations in Premalignant and In-Situ Breast |
1Z01SC009377-13 |
Steeg, Patricia |
|
Cell lines |
Not listed |
Molecular Markers for Breast Cancer |
1P50CA088843-010001 |
Sukumar, Saraswati |
Johns Hopkins University |
Large panel of breast tumors |
2000-2011 |
Selenium and Apoptosis in Cancer Prevention |
5P01CA045164-120005 |
Thompson, Henry |
AMC Cancer Researh Center |
Rat model |
Not listed |
Iron and Mammary Carcinogenesis |
5R01CA069241-03 |
Thompson, Henry |
AMC Cancer Researh Center |
Rat model |
1996-2000 |
Characterizing the Evolution of Pre-malignant Tissues at High Risk for Malignancy |
5R01CA135626-03 |
Tlsty, Thea |
University of California, San Francisco |
Breast tissue |
2008-2011 |
Risk Marker/Chemoprevention Target Identification |
2P50CA058207-090009 |
Tlsty, Thea |
University of California, San Francisco |
Human mammary epithelial cells and human breast tissue |
2003-2007 |
Developing mRNA Diagnostic Methods and Identifying Tumor Regulatory Networks |
5RC1CA145442-02 |
Tuschl, Thomas |
Rockefeller University |
Human tissue samples |
2009-2011 |
Psychosocial modulation of mammary carcinogenesis |
1F31CA130267-01 |
Yee, Jason Richard |
University of Chicago |
Rat model |
2007-2010 |
14-3-3zeta in ErbB2 Mediated Mammary Carcinogenesis |
5R01CA112567-03 |
Yu, Dihua |
University of Texas MD Anderson Cancer Center |
Mammary epithelial cells |
2005-2010 |
14-3-3zeta in Early Stages of Breast Cancer Progression |
5R01CA109570-03 |
Yu, Dihua |
University of Texas MD Anderson Cancer Center |
Mammary epithelial cells and tissues from patients |
2004-2010 |
Green tea catechins in precancerorus prevention |
1R21CA129772-01A2 |
Wang, Hwa-Chain Robert |
University of Tennessee Knoxville |
Cellular model |
2008-2010 |
Gene Amplification in Breast Cancer |
2P50CA068425-040007 |
Wigler, Michael |
Sloan-Kettering Institute for Cancer Research |
|
Not listed |